Skip to content
CATTI opens a cell and gene therapy training centre of excellence at the University of Guelph
The Canadian Advanced Therapies Training Institute (CATTI) Inc. has launched its first in-person training site at the University of Guelph…
Catamaran Bio selects OmniaBio as partner to develop and manufacture allogeneic CAR-NK cell therapies
Catamaran Bio Inc., a biotechnology company developing off-the-shelf NK cell therapies to treat cancer, and OmniaBio Inc., a CDMO focused on…
OmniaBio expands manufacturing footprint with second Hamilton location
OmniaBio Inc. has expanded its footprint by adding a new process and analytical development lab space at the McMaster University Medical Centre (MUMC)…
OmniaBio expands manufacturing footprint with second Hamilton location Read More »
Avectas, CCRM and OmniaBio Expand their Collaboration to Accelerate the Manufacture of Edited iPSCs Using SOLUPORE® Technology
Avectas, a cell
engineering technology business and CCRM, with its subsidiary OmniaBio Inc., a CDMO
that enables the development of cell therapies and…
Resolution Therapeutics and CCRM sign collaboration agreement, with work to be executed at OmniaBio
Resolution Therapeutics Limited (“Resolution”), a biopharmaceutical company developing macrophage cell therapies to treat advanced liver…
OmniaBio celebrates the beginning of construction
OmniaBio, CCRM and Stakeholders Celebrate Commencement of Construction of Hamilton Biomanufacturing Facility…
OmniaBio celebrates the beginning of construction Read More »
Ngen supports commercial scale manufacturing of cell and gene therapies in Canada
Next Generation Manufacturing Canada (NGen), the industry-led organization behind Canada’s Global Innovation Cluster for Advanced Manufacturing…
Ngen supports commercial scale manufacturing of cell and gene therapies in Canada Read More »
OmniaBio Inc. announces private investor
OmniaBio Inc., a subsidiary of CCRM, has executed a strategic agreement with Medipost, a global leader in stem cell therapeutics…
OmniaBio Inc. announces private investor Read More »
Funding from Ontario Government for OmniaBio
OmniaBio Inc., a subsidiary of CCRM, is the first project to be funded under the Invest Ontario Fund. Subject to reaching a definitive agreement, OmniaBio Inc…
Funding from Ontario Government for OmniaBio Read More »
Invest Ontario supports new biomanufacturing facility in Hamilton
Invest Ontario is supporting OmniaBio Inc. in launching a new biomanufacturing facility that will catalyze Ontario life sciences jobs and innovation…
Invest Ontario supports new biomanufacturing facility in Hamilton Read More »